An experimental gene-editing treatment lowered "bad" cholesterol and triglycerides in patients for at least a year after a single dose, according to an early-stage trial. Among those receiving the highest dose, bad cholesterol fell by an average of 53% and triglycerides by 48%.
The treatment uses CRISPR—a technology that allows scientists to make targeted changes to DNA—to switch off a gene in liver cells that helps regulate blood fats.
@kibcol1049 Is it a permanent cure, or the scam where the effect wears off after some time? I'm starting to see this more and more, where gene edits are only temporary so that the companies can sell their products again and again.
What is annoying is that technically it is very much feasible to make the changes permanent and hereditary in many cases.
